- Home
- HBB vs CATX Comparison
HBB vs CATX Comparison
Compare HBB & CATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HBB
- CATX
- Stock Information
- Founded
- HBB 1904
- CATX 1983
- Country
- HBB United States
- CATX United States
- Employees
- HBB N/A
- CATX N/A
- Industry
- HBB Home Furnishings
- CATX Medical/Dental Instruments
- Sector
- HBB Consumer Discretionary
- CATX Health Care
- Exchange
- HBB Nasdaq
- CATX Nasdaq
- Market Cap
- HBB 242.8M
- CATX 239.0M
- IPO Year
- HBB 2017
- CATX N/A
- Fundamental
- Price
- HBB $16.83
- CATX $3.44
- Analyst Decision
- HBB
- CATX Strong Buy
- Analyst Count
- HBB 0
- CATX 10
- Target Price
- HBB N/A
- CATX $13.00
- AVG Volume (30 Days)
- HBB 24.3K
- CATX 1.5M
- Earning Date
- HBB 07-30-2025
- CATX 08-11-2025
- Dividend Yield
- HBB 2.85%
- CATX N/A
- EPS Growth
- HBB 18.18
- CATX N/A
- EPS
- HBB 2.43
- CATX N/A
- Revenue
- HBB $659,788,000.00
- CATX $1,471,000.00
- Revenue This Year
- HBB N/A
- CATX N/A
- Revenue Next Year
- HBB N/A
- CATX N/A
- P/E Ratio
- HBB $6.92
- CATX N/A
- Revenue Growth
- HBB 5.46
- CATX N/A
- 52 Week Low
- HBB $13.25
- CATX $1.60
- 52 Week High
- HBB $31.78
- CATX $16.55
- Technical
- Relative Strength Index (RSI)
- HBB 40.71
- CATX 60.53
- Support Level
- HBB $16.58
- CATX $2.96
- Resistance Level
- HBB $17.60
- CATX $3.77
- Average True Range (ATR)
- HBB 0.80
- CATX 0.41
- MACD
- HBB -0.19
- CATX 0.02
- Stochastic Oscillator
- HBB 11.52
- CATX 73.78
About HBB Hamilton Beach Brands Holding Company
Hamilton Beach Brands Holding Co, through its subsidiaries, is engaged in consumer, commercial, and specialty small appliances and specialty retail. It designs, markets, and distributes small branded electric household and specialty housewares small appliances, as well as commercial products for restaurants, bars, and hotels. It has two operating segments Home and Commercial Products and Health.
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.